Michael Kates, Ph.D.
Head of Preclinical Development
Doylestown, Pennsylvania

​

Michael Kates joined DavosPharma in 2011.  He is responsible for business development and management of Davos’ fully Integrated Drug Discovery Service Platform. Prior to this, he worked as a medicinal chemist at both Wyeth Laboratories and DuPont-Merck. He holds a B.S. degree in chemistry, a Ph.D. from Villanova University and Post Doctorial Research Fellow at Brown University.

Mike is an Adjunct Associate Professor Medicinal Chemistry at the University of New England, School of Pharmacy and has 21 publications and contributed talks.